Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Erica Jordan Insider Profile
4 Followers
Erica Jordan, Chief Commercial Officer at Revance Therapeutics, holds 114.86K shares in Revance Therapeutics (Ticker: RVNC). Most recently, Erica Jordan Sold $2,392 shares of Revance Therapeutics on Apr 17, 2024 for an estimated value of 9.09K.
Erica Jordan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Commercial Officer
Roles that Erica Jordan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Erica Jordan
Erica Jordan's Trading History
List of latest transactions for each holding click on a transaction to see Erica Jordan's performance on stock
You May Also Like
Erica Jordan insider profile FAQ
What is the percentage of profitable transactions made by Erica Jordan?
The percentage of profitable transactions made by Erica Jordan is ―.
What is the average return per transaction made by Erica Jordan?
The average return per transaction made by Erica Jordan is ―.
What stocks does Erica Jordan hold?
Erica Jordan holds: RVNC stocks.
What was Erica Jordan’s latest transaction?
Erica Jordan latest transaction was an Informative Sell of $9.09K.
What was Erica Jordan's most profitable transaction?
Erica Jordan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Erica Jordan's role in Revance Therapeutics?
Erica Jordan's role in Revance Therapeutics is Chief Commercial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.